XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.25.2

Segments (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of Expenses by Segment | In addition, research and development and general and administrative expenses are significant segment expenses regularly provided to the CEO with the following categories (in thousands): Research and Development
|  | Three months ended June 30, |  |  | Six months ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands) |  |  | (in thousands) |
Clinical trial-related activities |  | $ | 6,390 |  |  | $ | 6,637 |  |  | $ | 14,081 |  |  | $ | 13,785 |
Personnel |  |  | 6,531 |  |  |  | 5,123 |  |  |  | 12,714 |  |  |  | 9,917 |
Chemistry, manufacturing and control |  |  | 2,484 |  |  |  | 2,994 |  |  |  | 4,776 |  |  |  | 5,161 |
Preclinical studies and activities |  |  | 616 |  |  |  | 295 |  |  |  | 1,028 |  |  |  | 632 |
Other costs |  |  | 631 |  |  |  | 799 |  |  |  | 428 |  |  |  | 664 |
Total research and development expenses |  | $ | 16,652 |  |  | $ | 15,848 |  |  | $ | 33,027 |  |  | $ | 30,159 |
General and Administrative
|  | Three months ended June 30, |  |  | Six months ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands) |  |  | (in thousands) |
Personnel |  | $ | 2,840 |  |  | $ | 2,899 |  |  | $ | 5,852 |  |  | $ | 5,693 |
Professional services |  |  | 1,743 |  |  |  | 975 |  |  |  | 3,124 |  |  |  | 2,048 |
Other costs |  |  | 1,935 |  |  |  | 1,811 |  |  |  | 3,751 |  |  |  | 3,830 |
Total general and administrative expenses |  | $ | 6,518 |  |  | $ | 5,685 |  |  | $ | 12,727 |  |  | $ | 11,571 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration